title: Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? A reply to Rosa et al.
authors.forename: Francisca
authors.initials: F
authors.lastname: Martínez
authors.forename: Kepa
authors.initials: K
authors.lastname: Latorre
authors.forename: Isabel
authors.initials: I
authors.lastname: Ramírez
authors.forename: Ezequiel
authors.initials: E
authors.lastname: Pérez-Campos
authors.forename: Iñaki
authors.initials: I
authors.lastname: Lete
mesh_terms: D003274:Contraceptive Devices, Female; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D006801:Humans; D011655:Pulmonary Embolism / Q000139:chemically induced*; D054556:Venous Thromboembolism / Q000139:chemically induced*
chemical_list: D003278:Contraceptives, Oral, Hormonal